Dr Shahrukh Hashmi is the acting Dean of Research at SSMC, Abu Dhabi, UAE. He graduated from Baqai Medical University, Pakistan, as the top graduate receiving Gold Medal from the President of Pakistan. He received a Master’s Degree (MPH) from Yale University, Connecticut, USA. He is a Diplomat of the American Board of Preventive Medicine/Public Health, Internal Medicine, and Hematology. Shahrukh has been at Mayo Clinic, Minnesota, USA for over 10 years. He started Mayo Clinic’s first BMT survivorship program and has served as PI or Co-PI on many industry-sponsored and NIH sponsored trials. Shahrukh’s research interests include premature ageing, artificial intelligence, and GVHD. He is also involved in Stem Cell Therapeutics particularly in regenerative haematology. He has authored over 250 articles in peer-reviewed journals, including in JAMA, Lancet, and in NEJM. Shahrukh chairs many national or international professional committees/groups including being the chair of the Worldwide Network for Blood and Marrow Transplant’s Nuclear Accident committee (Geneva, Switzerland), founding chair of American Society for Blood and Marrow Transplant Society’s Survivorship SIG (Chicago, Illinois), and co-chair of the Center for International Blood & Marrow Transplant Registry’s (CIBMTR) Health Services Committee (Milwaukee, Wisconsin). He is currently the chairperson of the Dept. of Hematology/Oncology at the SSMC, Abu Dhabi, UAE, and the chairperson of SEHA Oncology Council. He is also faculty at Khalifa University, UAE, and adjunct faculty at Mohamad Bin Zayed University of Artificial Intelligence, UAE.